|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 19/00 | |
| C12N 15/62 | |||
| C12N 15/55 | |||
| C12N 15/85 | |||
| A61P 9/00 | |||
| C12N 9/22 | |||
| A61K 38/46 |
| (11) | Number of the document | 2545080 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11754231.6 |
| Date of filing the European patent application | 2011-03-11 | |
| (97) | Date of publication of the European application | 2013-01-16 |
| (45) | Date of publication and mention of the grant of the patent | 2017-05-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/028233 |
| Date | 2011-03-11 |
| (87) | Number | WO 2011/113027 |
| Date | 2011-09-15 |
| (30) | Number | Date | Country code |
| 340066 P | 2010-03-12 | US |
| (72) |
QUINN, Anthony, US
HARVEY, Alex J., US
XIA, Zhinan, US
|
| (73) |
Alexion Pharmaceuticals, Inc.,
100 College Street, New Haven, CT 06510,
US
|
| (54) | NPP1 FUSION PROTEINS |
| NPP1 FUSION PROTEINS |